than 10,000 beds. It also operates 3167 retail pharmacies; approximately 500 retail healthcare centers; approximately 148 telemedicine units; and 1 research foundation.
Company has reported excellent results for H1FY19, income has improved by 13.13 percent YoY to Rs 4000.51 crore while PAT increased by 31.13 percent to Rs 139.14 crore as against Rs 106.11 crore. PBDIT grew by 22.69 percent to Rs 484.46 crore during H1FY19. On technical front stock has formed strong higher top higher bottom formation which is bullish in its nature. We are recommending a buy in staggered manner for medium to long term.